Genelabs Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of pharmaceutical products to improve human health. It is developing Prestara (prasterone), an investigational drug for women with systemic lupus erythematosus. The company also pursues drug discovery of novel anti viral compounds for the treatment of hepatitis C virus infections and advances pre clinical development of compounds in this program. Its products in pre clinical stage include HCV NSSb Polymerase and HCV NSSa for the treatment of Hepatitis C virus infection. Genelabs Technologies, in partnership with Glaxosmithkline, is also developing HEV Vaccine for the prevention of disease...